Experience in a short-term trial with 4-aminopyridine in cerebellar ataxia

J Neurol. 2013 Aug;260(8):2175-6. doi: 10.1007/s00415-013-7029-5. Epub 2013 Jul 4.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • 4-Aminopyridine / adverse effects
  • 4-Aminopyridine / therapeutic use*
  • Cerebellar Ataxia / drug therapy*
  • Cerebellar Ataxia / genetics
  • Chronic Disease
  • Disability Evaluation
  • Humans
  • Potassium Channel Blockers / adverse effects
  • Potassium Channel Blockers / therapeutic use*

Substances

  • Potassium Channel Blockers
  • 4-Aminopyridine